Drug intelligence / Profile preview

AminoZorb

Development stage
Unknown
Lead developer
All American Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

AminoZorb is a patented dietary supplement and nutraceutical developed by Dr. Jeff Golini at All American Pharmaceuticals. It is a branched-chain amino acid (BCAA) formulation featuring a 2:1:1 ratio of L-leucine, L-isoleucine, and L-valine. The product utilizes an advanced delivery system and enzymatically fermented amino acids to enhance absorption and support muscle recovery, growth, and overall athletic performance. Some formulations, such as AminoZorb Elite 21, include a comprehensive profile of essential, non-essential, and conditionally essential amino acids along with GlutaZorb (a stable form of glutamine). It is primarily marketed within the sports nutrition industry for athletes seeking improved supplementation efficiency and muscle support.

Brand names
AminoZorbAminoZorb Elite 21
02

Targets

mTOR (Mammalian target of rapamycin kinase)

Beyond the preview

Go deeper on AminoZorb.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AminoZorb.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call